165 related articles for article (PubMed ID: 17265528)
1. Features of the metabolic syndrome and prostate cancer in African-American men.
Beebe-Dimmer JL; Dunn RL; Sarma AV; Montie JE; Cooney KA
Cancer; 2007 Mar; 109(5):875-81. PubMed ID: 17265528
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in risk of prostate cancer associated with metabolic syndrome.
Beebe-Dimmer JL; Nock NL; Neslund-Dudas C; Rundle A; Bock CH; Tang D; Jankowski M; Rybicki BA
Urology; 2009 Jul; 74(1):185-90. PubMed ID: 19428088
[TBL] [Abstract][Full Text] [Related]
3. Association between family history of prostate and breast cancer among African-American men with prostate cancer.
Beebe-Dimmer JL; Drake EA; Dunn RL; Bock CH; Montie JE; Cooney KA
Urology; 2006 Nov; 68(5):1072-6. PubMed ID: 17095075
[TBL] [Abstract][Full Text] [Related]
4. Association of Anthropometric Measures with Prostate Cancer among African American Men in the NCI-Maryland Prostate Cancer Case-Control Study.
Pichardo MS; Smith CJ; Dorsey TH; Loffredo CA; Ambs S
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):936-944. PubMed ID: 29784730
[No Abstract] [Full Text] [Related]
5. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.
Blanc-Lapierre A; Spence A; Karakiewicz PI; Aprikian A; Saad F; Parent MÉ
BMC Public Health; 2015 Sep; 15():913. PubMed ID: 26385727
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
Meis SB; Schuster D; Gaillard T; Osei K
Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
[TBL] [Abstract][Full Text] [Related]
7. Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study.
Beebe-Dimmer JL; Faerber GJ; Morgenstern H; Werny D; Wojno K; Halstead-Nussloch B; Cooney KA
Urology; 2008 Apr; 71(4):554-60. PubMed ID: 18308373
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome and risk of prostate cancer in Italy.
Pelucchi C; Serraino D; Negri E; Montella M; Dellanoce C; Talamini R; La Vecchia C
Ann Epidemiol; 2011 Nov; 21(11):835-41. PubMed ID: 21982487
[TBL] [Abstract][Full Text] [Related]
9. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Hammarsten J; Högstedt B
Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
[TBL] [Abstract][Full Text] [Related]
10. Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Barrington WE; Schenk JM; Etzioni R; Arnold KB; Neuhouser ML; Thompson IM; Lucia MS; Kristal AR
JAMA Oncol; 2015 Jun; 1(3):342-9. PubMed ID: 26181184
[TBL] [Abstract][Full Text] [Related]
11. Central adiposity and Prostate Cancer in a Black Population.
Nemesure B; Wu SY; Hennis A; Leske MC;
Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):851-8. PubMed ID: 22402288
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.
Sarma AV; Dunn RL; Lange LA; Ray A; Wang Y; Lange EM; Cooney KA
Prostate; 2008 Feb; 68(3):296-305. PubMed ID: 18163429
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans.
Beebe-Dimmer JL; Zuhlke KA; Ray AM; Lange EM; Cooney KA
Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):362-8. PubMed ID: 20697428
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
15. The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study.
Wallner LP; Morgenstern H; McGree ME; Jacobson DJ; St Sauver JL; Jacobsen SJ; Sarma AV
BJU Int; 2011 Mar; 107(6):929-35. PubMed ID: 20880183
[TBL] [Abstract][Full Text] [Related]
16. Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors: a report from the AAASPS.
Ruland S; Hung E; Richardson D; Misra S; Gorelick PB;
Arch Neurol; 2005 Mar; 62(3):386-90. PubMed ID: 15767503
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome is associated with aggressive prostate cancer regardless of race.
Guerrios-Rivera L; Howard LE; Wiggins EK; Hoyo C; Grant DJ; Erickson TR; Ithisuphalap J; Freedland AR; Vidal AC; Fowke JH; Freedland SJ
Cancer Causes Control; 2023 Mar; 34(3):213-221. PubMed ID: 36450931
[TBL] [Abstract][Full Text] [Related]
18. Anthropometric measures, presence of metabolic syndrome, and adherence to physical activity guidelines among African American church members, Dallas, Texas, 2008.
Shuval K; DeVahl J; Tong L; Gimpel N; Lee JJ; DeHaven MJ
Prev Chronic Dis; 2011 Jan; 8(1):A18. PubMed ID: 21159230
[TBL] [Abstract][Full Text] [Related]
19. Relationship of early-onset baldness to prostate cancer in African-American men.
Zeigler-Johnson C; Morales KH; Spangler E; Chang BL; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):589-96. PubMed ID: 23532004
[TBL] [Abstract][Full Text] [Related]
20. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
